Pivekimab, also IBAT®, constitutes the innovative genetically engineered cloned antibody developed to specifically interact with or neutralize interleukin-6, a important molecule implicated with various...
The Verdict
ClassificationUnsure
ConfidenceMedium confidence
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/5df07c2f-1985-438d-87cc-11ddf53f9403)